Leukocyte-Rich vs. Leukocyte-Poor Platelet-Rich Plasma for the Treatment of Knee Osteoarthritis
- PMID: 36672650
- PMCID: PMC9856144
- DOI: 10.3390/biomedicines11010141
Leukocyte-Rich vs. Leukocyte-Poor Platelet-Rich Plasma for the Treatment of Knee Osteoarthritis
Abstract
Knee osteoarthritis (OA) is a well-established form of OA and accounts for nearly 4/5 of global OA burden […].
Conflict of interest statement
The authors declare no conflict of interest.
References
-
- Gupta A., Maffulli N., Rodriguez H.C., Mistovich R.J., Delfino K., Cady C., Fauser A.M., Cundiff E.D., Martinez M.A., Potty A.G. Cell-free stem cell-derived extract formulation for treatment of knee osteoarthritis: Study protocol for a preliminary non-randomized, open-label, multi-center feasibility and safety study. J. Orthop. Surg. Res. 2021;16:514. doi: 10.1186/s13018-021-02672-3. - DOI - PMC - PubMed
-
- Park Y.B., Kim J.H., Ha C.W., Lee D.H. Clinical efficacy of platelet-rich plasma injection and its association with growth factors in the treatment of mild to moderate knee osteoarthritis: A randomized double blind controlled clinical trial as compared with hyaluronic acid. Am. J. Sports Med. 2021;49:487–496. doi: 10.1177/0363546520986867. - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources
